HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-OCT-15 5E91 TITLE TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A, TITLE 2 R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4- TITLE 3 (MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TGF-BETA RECEPTOR TYPE-2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 237-549; COMPND 5 SYNONYM: TGFR-2,TGF-BETA TYPE II RECEPTOR,TRANSFORMING GROWTH FACTOR- COMPND 6 BETA RECEPTOR TYPE II,TBETAR-II; COMPND 7 EC: 2.7.11.30; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TGFBR2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF REVDAT 3 27-SEP-23 5E91 1 REMARK REVDAT 2 18-APR-18 5E91 1 JRNL REMARK REVDAT 1 11-MAY-16 5E91 0 JRNL AUTH A.J.TEBBEN,M.RUZANOV,M.GAO,D.XIE,S.E.KIEFER,C.YAN, JRNL AUTH 2 J.A.NEWITT,L.ZHANG,K.KIM,H.LU,L.M.KOPCHO,S.SHERIFF JRNL TITL CRYSTAL STRUCTURES OF APO AND INHIBITOR-BOUND TGF BETA R2 JRNL TITL 2 KINASE DOMAIN: INSIGHTS INTO TGF BETA R ISOFORM SELECTIVITY. JRNL REF ACTA CRYSTALLOGR D STRUCT V. 72 658 2016 JRNL REF 2 BIOL JRNL REFN ISSN 2059-7983 JRNL PMID 27139629 JRNL DOI 10.1107/S2059798316003624 REMARK 2 REMARK 2 RESOLUTION. 2.42 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.42 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 14523 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.890 REMARK 3 FREE R VALUE TEST SET COUNT : 710 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.42 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.46 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2878 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2174 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2749 REMARK 3 BIN R VALUE (WORKING SET) : 0.2171 REMARK 3 BIN FREE R VALUE : 0.2246 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.48 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 129 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2252 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 53 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 62.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.79110 REMARK 3 B22 (A**2) : -5.36460 REMARK 3 B33 (A**2) : 4.57350 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.335 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.346 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.234 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.340 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.235 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.891 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2360 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3233 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 778 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 49 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 378 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2360 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 311 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2730 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.42 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.13 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5E91 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1000214555. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAR-15 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14588 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.420 REMARK 200 RESOLUTION RANGE LOW (A) : 49.080 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.42 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : 0.63100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 3TZM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS-HCL, PH 8.5, 150 MM MGCL2, REMARK 280 24%(W/V) PEG4000, 20%(V/V) GLCYEROL, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.43000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.53500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.88500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.53500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.43000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.88500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 234 REMARK 465 HIS A 235 REMARK 465 MET A 236 REMARK 465 HIS A 237 REMARK 465 ASN A 238 REMARK 465 THR A 239 REMARK 465 GLN A 265 REMARK 465 ASN A 266 REMARK 465 THR A 267 REMARK 465 SER A 268 REMARK 465 GLU A 269 REMARK 465 GLN A 270 REMARK 465 PHE A 271 REMARK 465 LEU A 544 REMARK 465 ASP A 545 REMARK 465 ARG A 546 REMARK 465 LEU A 547 REMARK 465 SER A 548 REMARK 465 GLY A 549 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 240 CG CD OE1 OE2 REMARK 470 GLU A 245 CG CD OE1 OE2 REMARK 470 ARG A 254 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 264 CG CD CE NZ REMARK 470 LYS A 300 CE NZ REMARK 470 LYS A 314 CE NZ REMARK 470 GLU A 316 CG CD OE1 OE2 REMARK 470 LEU A 317 CG CD1 CD2 REMARK 470 ARG A 348 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 370 CG CD NE CZ NH1 NH2 REMARK 470 SER A 409 OG REMARK 470 VAL A 410 CG1 CG2 REMARK 470 ASP A 411 CG OD1 OD2 REMARK 470 ASN A 415 CG OD1 ND2 REMARK 470 SER A 416 OG REMARK 470 GLU A 437 CG CD OE1 OE2 REMARK 470 ASN A 438 CG OD1 ND2 REMARK 470 VAL A 439 CG1 CG2 REMARK 470 GLU A 440 CG CD OE1 OE2 REMARK 470 GLU A 466 CG CD OE1 OE2 REMARK 470 LYS A 468 CG CD CE NZ REMARK 470 GLU A 471 CG CD OE1 OE2 REMARK 470 SER A 476 OG REMARK 470 LYS A 477 CD CE NZ REMARK 470 GLU A 480 CG CD OE1 OE2 REMARK 470 HIS A 481 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 508 CG CD OE1 NE2 REMARK 470 MET A 512 CG SD CE REMARK 470 GLU A 540 CG CD OE1 OE2 REMARK 470 GLU A 542 CG CD OE1 OE2 REMARK 470 HIS A 543 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 247 -64.09 -103.76 REMARK 500 LYS A 300 114.75 -39.90 REMARK 500 LEU A 308 -63.86 -100.43 REMARK 500 ASP A 379 43.02 -148.25 REMARK 500 ASP A 397 64.81 61.39 REMARK 500 ASN A 415 86.95 -152.71 REMARK 500 SER A 416 -91.74 51.67 REMARK 500 VAL A 439 -168.65 -72.19 REMARK 500 GLU A 440 -27.68 71.95 REMARK 500 HIS A 481 79.30 -117.25 REMARK 500 LEU A 492 -65.40 -94.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5L4 A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5E8S RELATED DB: PDB REMARK 900 RELATED ID: 5E8T RELATED DB: PDB REMARK 900 RELATED ID: 5E8U RELATED DB: PDB REMARK 900 RELATED ID: 5E8V RELATED DB: PDB REMARK 900 RELATED ID: 5E8W RELATED DB: PDB REMARK 900 RELATED ID: 5E8X RELATED DB: PDB REMARK 900 RELATED ID: 5E8Y RELATED DB: PDB REMARK 900 RELATED ID: 5E8Z RELATED DB: PDB REMARK 900 RELATED ID: 5E90 RELATED DB: PDB REMARK 900 RELATED ID: 5E92 RELATED DB: PDB DBREF 5E91 A 237 549 UNP P37173 TGFR2_HUMAN 237 549 SEQADV 5E91 GLY A 234 UNP P37173 EXPRESSION TAG SEQADV 5E91 HIS A 235 UNP P37173 EXPRESSION TAG SEQADV 5E91 MET A 236 UNP P37173 EXPRESSION TAG SEQADV 5E91 ALA A 431 UNP P37173 GLU 431 ENGINEERED MUTATION SEQADV 5E91 ALA A 433 UNP P37173 ARG 433 ENGINEERED MUTATION SEQADV 5E91 ALA A 485 UNP P37173 GLU 485 ENGINEERED MUTATION SEQADV 5E91 ALA A 488 UNP P37173 LYS 488 ENGINEERED MUTATION SEQADV 5E91 ALA A 493 UNP P37173 ARG 493 ENGINEERED MUTATION SEQADV 5E91 ALA A 495 UNP P37173 ARG 495 ENGINEERED MUTATION SEQRES 1 A 316 GLY HIS MET HIS ASN THR GLU LEU LEU PRO ILE GLU LEU SEQRES 2 A 316 ASP THR LEU VAL GLY LYS GLY ARG PHE ALA GLU VAL TYR SEQRES 3 A 316 LYS ALA LYS LEU LYS GLN ASN THR SER GLU GLN PHE GLU SEQRES 4 A 316 THR VAL ALA VAL LYS ILE PHE PRO TYR GLU GLU TYR ALA SEQRES 5 A 316 SER TRP LYS THR GLU LYS ASP ILE PHE SER ASP ILE ASN SEQRES 6 A 316 LEU LYS HIS GLU ASN ILE LEU GLN PHE LEU THR ALA GLU SEQRES 7 A 316 GLU ARG LYS THR GLU LEU GLY LYS GLN TYR TRP LEU ILE SEQRES 8 A 316 THR ALA PHE HIS ALA LYS GLY ASN LEU GLN GLU TYR LEU SEQRES 9 A 316 THR ARG HIS VAL ILE SER TRP GLU ASP LEU ARG LYS LEU SEQRES 10 A 316 GLY SER SER LEU ALA ARG GLY ILE ALA HIS LEU HIS SER SEQRES 11 A 316 ASP HIS THR PRO CYS GLY ARG PRO LYS MET PRO ILE VAL SEQRES 12 A 316 HIS ARG ASP LEU LYS SER SER ASN ILE LEU VAL LYS ASN SEQRES 13 A 316 ASP LEU THR CYS CYS LEU CYS ASP PHE GLY LEU SER LEU SEQRES 14 A 316 ARG LEU ASP PRO THR LEU SER VAL ASP ASP LEU ALA ASN SEQRES 15 A 316 SER GLY GLN VAL GLY THR ALA ARG TYR MET ALA PRO GLU SEQRES 16 A 316 VAL LEU ALA SER ALA MET ASN LEU GLU ASN VAL GLU SER SEQRES 17 A 316 PHE LYS GLN THR ASP VAL TYR SER MET ALA LEU VAL LEU SEQRES 18 A 316 TRP GLU MET THR SER ARG CYS ASN ALA VAL GLY GLU VAL SEQRES 19 A 316 LYS ASP TYR GLU PRO PRO PHE GLY SER LYS VAL ARG GLU SEQRES 20 A 316 HIS PRO CYS VAL ALA SER MET ALA ASP ASN VAL LEU ALA SEQRES 21 A 316 ASP ALA GLY ARG PRO GLU ILE PRO SER PHE TRP LEU ASN SEQRES 22 A 316 HIS GLN GLY ILE GLN MET VAL CYS GLU THR LEU THR GLU SEQRES 23 A 316 CYS TRP ASP HIS ASP PRO GLU ALA ARG LEU THR ALA GLN SEQRES 24 A 316 CYS VAL ALA GLU ARG PHE SER GLU LEU GLU HIS LEU ASP SEQRES 25 A 316 ARG LEU SER GLY HET 5L4 A 601 55 HETNAM 5L4 3-AMINO-6-[4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4- HETNAM 2 5L4 YL)PYRIDIN-3-YL]PYRAZINE-2-CARBOXAMIDE FORMUL 2 5L4 C22 H24 N6 O3 FORMUL 3 HOH *53(H2 O) HELIX 1 AA1 GLU A 283 SER A 295 1 13 HELIX 2 AA2 ASP A 296 LYS A 300 5 5 HELIX 3 AA3 ASN A 332 HIS A 340 1 9 HELIX 4 AA4 SER A 343 SER A 363 1 21 HELIX 5 AA5 LYS A 381 SER A 383 5 3 HELIX 6 AA6 THR A 421 MET A 425 5 5 HELIX 7 AA7 ALA A 426 ALA A 431 1 6 HELIX 8 AA8 GLU A 440 ARG A 460 1 21 HELIX 9 AA9 CYS A 461 GLY A 465 5 5 HELIX 10 AB1 CYS A 483 LEU A 492 1 10 HELIX 11 AB2 PRO A 501 ASN A 506 5 6 HELIX 12 AB3 HIS A 507 TRP A 521 1 15 HELIX 13 AB4 ASP A 524 ARG A 528 5 5 HELIX 14 AB5 THR A 530 LEU A 541 1 12 SHEET 1 AA1 5 ILE A 244 LYS A 252 0 SHEET 2 AA1 5 GLU A 257 LEU A 263 -1 O LYS A 262 N GLU A 245 SHEET 3 AA1 5 THR A 273 PRO A 280 -1 O ILE A 278 N GLU A 257 SHEET 4 AA1 5 LYS A 319 ALA A 326 -1 O TYR A 321 N PHE A 279 SHEET 5 AA1 5 PHE A 307 LYS A 314 -1 N ARG A 313 O GLN A 320 SHEET 1 AA2 2 ILE A 375 VAL A 376 0 SHEET 2 AA2 2 LEU A 402 ARG A 403 -1 O LEU A 402 N VAL A 376 SHEET 1 AA3 2 ILE A 385 VAL A 387 0 SHEET 2 AA3 2 CYS A 393 LEU A 395 -1 O CYS A 394 N LEU A 386 CISPEP 1 ASN A 415 SER A 416 0 -2.04 SITE 1 AC1 16 VAL A 250 VAL A 258 ALA A 275 LYS A 277 SITE 2 AC1 16 LEU A 305 THR A 325 ALA A 326 PHE A 327 SITE 3 AC1 16 HIS A 328 ALA A 329 GLY A 331 ASN A 332 SITE 4 AC1 16 MET A 373 SER A 383 LEU A 386 ASP A 397 CRYST1 64.860 75.770 75.070 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015418 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013198 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013321 0.00000